Injectables (Ozempic, Wegovy) might require a 1-week hold in specific higher risk patients
Ozempic is administered as a once-weekly subcutaneous injection , typically starting at 0.25 mg and gradually titrated upwards to therapeutic doses of 0.5 mg, 1 mg, or 2 mg, depending on individual glycaemic control and tolerability
This weekly regimen is based on the drug's pharmacokinetic profile, with a half-life of approximately one week (approximately 165 hours), which allows for steady-state plasma concentrations to be maintained with weekly administration
Serious side effects are very uncommon but can occur, making it crucial to seek guidance from a healthcare professional
A 20 mg retatrutide vial with 2 mL of bacteriostatic water makes 10 mg/mL, where 9 mg draws 90 units and 10 mg draws 100 units